Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Fungal Group Zygomycota

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Fungal Phylum Microsporidia

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Cryptococcal Meningitis

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...

Toxoplasmosis

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

Chest·2002

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

Blastomycosis.

Alison Werner¹, Frank Norton

¹Brykenwood Veterinary Clinic, Austin, Texas, USA.

Compendium (Yardley, PA)

|August 27, 2011

Summary

Blastomycosis causes severe illness and death in people and dogs, but is rare in cats. Diagnosis is challenging due to difficulties in organism isolation and culturing, hindering timely treatment.

Area of Science:

Veterinary Mycology
Infectious Diseases
Comparative Pathology

Background:

Blastomycosis has been a recognized cause of significant morbidity and mortality in humans and canines for over a century.
The fungal infection is notably rare in feline populations.
Challenges in isolating the causative organism and difficulties in culturing environmental samples impede disease management.

Purpose of the Study:

To review recent advancements in understanding blastomycosis.
To highlight challenges in diagnosing blastomycosis, particularly in cats.
To discuss progress in treatment and prevention strategies for blastomycosis.

Main Methods:

Comprehensive literature review of epidemiological studies.
Analysis of serological diagnostic advancements.

Related Experiment Videos

Last Updated: May 29, 2026

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Toxoplasma gondii Cyst Wall Formation in Activated Bone Marrow-derived Macrophages and Bradyzoite Conditions

Published on: August 12, 2010

Evaluation of clinical presentations across species.

Review of emerging antifungal therapies.

Assessment of vaccine development progress.

Main Results:

Blastomycosis remains a significant health concern with high impact in dogs and humans.
Diagnostic delays are common due to difficulties in organism detection via cytology.
Newer diagnostic and therapeutic approaches are emerging.
Vaccine development shows promise for future prevention.

Conclusions:

Timely diagnosis of blastomycosis is a critical unmet need, especially when cytologic samples are unrewarding.
Advances in epidemiology, serology, and antifungal treatments offer improved management options.
Ongoing research into novel culturing methods and vaccine development holds potential for controlling blastomycosis.